Phase I study of ON 01910.Na, a novel polo-like kinase 1 pathway modulator, administered as a weekly 24-hour continuous infusion in patients with advanced cancer

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 26; no. 15_suppl; p. 2515
Main Authors	Vainshtein, J. M., Ghalib, M. H., Kumar, M., Chaudhary, I., Maniar, M., Taft, D. R., Cosenza, S., Reddy, E. P., Goel, S., Mani, S.
Format	Journal Article
Language	English
Published	20.05.2008
Online Access	Get full text

Loading…